Buchumschlag

Develop and validate a computable phenotype for the identification of Alzheimer's disease patients using electronic health record data

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Xing He, Ruoqi Wei, Yu Huang, Zhaoyi Chen, Tianchen Lyu, Sarah Bost, Jiayi Tong, Lu Li, Yujia Zhou, Zhao Li, Jingchuan Guo, Huilin Tang, Fei Wang, Steven DeKosky, Hua Xu, Yong Chen, Rui Zhang, Jie Xu, Yi Guo, Yonghui Wu, Jiang Bian
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
von: Fang Wang, et al.
Veröffentlicht: (2025)

Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS
von: Dustin B. Hammers, et al.
Veröffentlicht: (2026)

Feasibility, validity, and normative data for the remote Uniform Data Set neuropsychological battery at the University of Pennsylvania Alzheimer's Disease Research Center
von: Katherine Hackett, et al.
Veröffentlicht: (2024)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
von: Xiang‐Sha Yin, et al.
Veröffentlicht: (2025)

Factors associated with discordant visual and quantitative amyloid PET results
von: Jasmin E Guevara, et al.
Veröffentlicht: (2026)

Utilizing deep learning to predict Alzheimer's disease and mild cognitive impairment with optical coherence tomography
von: Jacqueline Chua, et al.
Veröffentlicht: (2025)

Impact of sleep disruptions on gray matter structural covariance networks across the Alzheimer's disease continuum
von: Xiao Luo, et al.
Veröffentlicht: (2025)

Establishment and verification of reference intervals for Alzheimer's disease plasma biomarkers based on evaluation of pre‐analytical procedures: a multicenter study
von: Wencan Jiang, et al.
Veröffentlicht: (2025)

Data‐driven neuropsychological phenotypes in the Baltimore Longitudinal Study of Aging
von: Caitlin M. Terao, et al.
Veröffentlicht: (2025)

Long‐term Alzheimer's disease mortality prediction in adults aged ≥60 years: A prospective cohort study benchmarking survival machine learning algorithms
von: Xiaoping Huang, et al.
Veröffentlicht: (2025)

Assessing Alzheimer's disease via plasma extracellular vesicle–derived mRNA
von: Le Hoang Phu Pham, et al.
Veröffentlicht: (2024)

Detecting time‐varying genetic effects in Alzheimer's disease using a longitudinal genome‐wide association studies model
von: Xiaowei Zhuang, et al.
Veröffentlicht: (2024)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
von: Yuhan Xie, et al.
Veröffentlicht: (2025)

The Rapid Naming Test: Neuroanatomical validity and clinical utility
von: Kelly J. Atkins, et al.
Veröffentlicht: (2025)

Deep medullary vein abnormalities associated with cognitive function and Alzheimer's disease plasma biomarkers in dementia‐free older adults: A population‐based study
von: Dejia Yin, et al.
Veröffentlicht: (2026)

Reliability and validity of the Rhode Island Mobile Cognitive Assessment Tool
von: Laura E. Korthauer, et al.
Veröffentlicht: (2026)

Lecanemab treatment modulates brain volume and cerebrospinal fluid pathways in early Alzheimer's disease: Insights from longitudinal magnetic resonance imaging
von: Yuxin Li, et al.
Veröffentlicht: (2026)

Lower odor identification in subjective cognitive decline: a meta‐analysis
von: Benoît Jobin, et al.
Veröffentlicht: (2025)

Odor identification and progression to dementia: The role of odor characteristics and set size
von: Eva Dickmänken, et al.
Veröffentlicht: (2024)

Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease
von: Peter Thomas, et al.
Veröffentlicht: (2024)

Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology
von: Ece Bayram, et al.
Veröffentlicht: (2025)

Risk prediction of mild cognitive impairment using electronic health record data
von: Gang Li, et al.
Veröffentlicht: (2025)

Advancing dementia identification using machine learning and real‐world sequential health data
von: Cristian Gonzalez‐Prieto, et al.
Veröffentlicht: (2026)

Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
von: Nicholas R. Ray, et al.
Veröffentlicht: (2024)

Plasma p‐tau217 and APOE genotype: Prodromal Alzheimer's disease staging
von: Ann M. Stowe, et al.
Veröffentlicht: (2026)

Culturally adapted cognitive assessment tool for Indigenous communities in Brazil: Content, construct, and criterion validity
von: Camila Carlos Bezerra, et al.
Veröffentlicht: (2024)

Clinical validation of the Lilly SP‐X P‐tau217 assay: Performance in underrepresented cohorts
von: Michael E. Hodsdon, et al.
Veröffentlicht: (2025)

Cardiometabolic disease, cognitive decline, and brain structure in middle and older age
von: Abigail Dove, et al.
Veröffentlicht: (2024)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
von: María A. Rodríguez‐Santiago, et al.
Veröffentlicht: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
von: Juliana N. Souza‐Talarico, et al.
Veröffentlicht: (2025)

Correction to “Culturally adapted cognitive assessment tool for Indigenous communities in Brazil: Content, construct, and criterion validity”
Veröffentlicht: (2025)

Preliminary validation of the Virtual Kitchen Challenge as an objective and sensitive measure of everyday function associated with cerebrovascular disease
von: Sophia L. Holmqvist, et al.
Veröffentlicht: (2024)

Midlife sensory and motor functions improve prediction of blood‐based measures of neurodegeneration and Alzheimer's disease in late middle‐age
von: Adam J. Paulsen, et al.
Veröffentlicht: (2024)

Diagnostic utility of plasma p‐tau217 differs by Alzheimer's disease tau‐based subtypes
von: Seyed Hani Hojjati, et al.
Veröffentlicht: (2025)

Association between BrainAGE and Alzheimer's disease biomarkers
von: Yousaf Abughofah, et al.
Veröffentlicht: (2025)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
von: Thomas Claessen, et al.
Veröffentlicht: (2025)

Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
von: Diana Esteller‐Gauxax, et al.
Veröffentlicht: (2026)

Treating Alzheimer's disease in a person living with HIV
von: David B. Clifford, et al.
Veröffentlicht: (2026)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
von: Samantha C. Burnham, et al.
Veröffentlicht: (2026)

Diagnostic performance of light reflex pupillometry in Alzheimer's disease
von: Mathias Holsey Gramkow, et al.
Veröffentlicht: (2024)